
doi: 10.17615/ct54-nv40
BACKGROUND: In 2013-2014, we achieved 89% adult HIV testing coverage using a hybrid testing approach in 32 communities in Uganda and Kenya (SEARCH: NCT01864603). To inform scalability, we sought to determine: (1) overall cost and efficiency of this approach; and (2) costs associated with point-of-care (POC) CD4 testing, multidisease services, and community mobilization. METHODS: We applied microcosting methods to estimate costs of population-wide HIV testing in 12 SEARCH trial communities. Main intervention components of the hybrid approach are census, multidisease community health campaigns (CHC), and home-based testing for CHC nonattendees. POC CD4 tests were provided for all HIV-infected participants. Data were extracted from expenditure records, activity registers, staff interviews, and time and motion logs. RESULTS: The mean cost per adult tested for HIV was $20.5 (range: $17.1-$32.1) (2014 US$), including a POC CD4 test at $16 per HIV+ person identified. Cost per adult tested for HIV was $13.8 at CHC vs. $31.7 by home-based testing. The cost per HIV+ adult identified was $231 ($87-$1245), with variability due mainly to HIV prevalence among persons tested (ie, HIV positivity rate). The marginal costs of multidisease testing at CHCs were $1.16/person for hypertension and diabetes, and $0.90 for malaria. Community mobilization constituted 15.3% of total costs. CONCLUSIONS: The hybrid testing approach achieved very high HIV testing coverage, with POC CD4, at costs similar to previously reported mobile, home-based, or venue-based HIV testing approaches in sub-Saharan Africa. By leveraging HIV infrastructure, multidisease services were offered at low marginal costs.
Rural Population, Operations Research, Epidemiology, Cost-Benefit Analysis, Point-of-Care Systems, community-based HIV testing and counseling, Clinical Sciences, Clinical Trials and Supportive Activities, 610, HIV Infections, Clinical sciences, Health Promotion, Clinical Research, Virology, 616, Health Sciences, Behavioral and Social Science, cost, Humans, Mass Screening, Uganda, Randomized Controlled Trials as Topic, Public health, Biomedical and Clinical Sciences, Health Services, Kenya, East Africa, CD4 Lymphocyte Count, Infectious Diseases, Good Health and Well Being, Medical Microbiology, efficiency, Public Health and Health Services, Sexually Transmitted Infections, HIV/AIDS, Public Health, Rural Health Services, Infection, Mobile Health Units
Rural Population, Operations Research, Epidemiology, Cost-Benefit Analysis, Point-of-Care Systems, community-based HIV testing and counseling, Clinical Sciences, Clinical Trials and Supportive Activities, 610, HIV Infections, Clinical sciences, Health Promotion, Clinical Research, Virology, 616, Health Sciences, Behavioral and Social Science, cost, Humans, Mass Screening, Uganda, Randomized Controlled Trials as Topic, Public health, Biomedical and Clinical Sciences, Health Services, Kenya, East Africa, CD4 Lymphocyte Count, Infectious Diseases, Good Health and Well Being, Medical Microbiology, efficiency, Public Health and Health Services, Sexually Transmitted Infections, HIV/AIDS, Public Health, Rural Health Services, Infection, Mobile Health Units
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
